Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;22(1):129-149.
doi: 10.1002/wps.21037.

Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

Affiliations

Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

Samuele Cortese et al. World Psychiatry. 2023 Feb.

Abstract

Neurodevelopmental disorders - including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, communication disorders, intellectual disability, motor disorders, specific learning disorders, and tic disorders - manifest themselves early in development. Valid, reliable and broadly usable biomarkers supporting a timely diagnosis of these disorders would be highly relevant from a clinical and public health standpoint. We conducted the first systematic review of studies on candidate diagnostic biomarkers for these disorders in children and adolescents. We searched Medline and Embase + Embase Classic with terms relating to biomarkers until April 6, 2022, and conducted additional targeted searches for genome-wide association studies (GWAS) and neuroimaging or neurophysiological studies carried out by international consortia. We considered a candidate biomarker as promising if it was reported in at least two independent studies providing evidence of sensitivity and specificity of at least 80%. After screening 10,625 references, we retained 780 studies (374 biochemical, 203 neuroimaging, 133 neurophysiological and 65 neuropsychological studies, and five GWAS), including a total of approximately 120,000 cases and 176,000 controls. While the majority of the studies focused simply on associations, we could not find any biomarker for which there was evidence - from two or more studies from independent research groups, with results going into the same direction - of specificity and sensitivity of at least 80%. Other important metrics to assess the validity of a candidate biomarker, such as positive predictive value and negative predictive value, were infrequently reported. Limitations of the currently available studies include mostly small sample size, heterogeneous approaches and candidate biomarker targets, undue focus on single instead of joint biomarker signatures, and incomplete accounting for potential confounding factors. Future multivariable and multi-level approaches may be best suited to find valid candidate biomarkers, which will then need to be validated in external, independent samples and then, importantly, tested in terms of feasibility and cost-effectiveness, before they can be implemented in daily clinical practice.

Keywords: ADHD; Biological markers; autism spectrum disorder; communication disorders; genome-wide association studies; intellectual disabil­ity; motor disorders; neurodevelopmental disorders; neuroimaging; neurophysiology; specific learning disorders; tic disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram showing selection of studies for inclusion

Similar articles

Cited by

References

    1. FDA‐NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and other Tools) resource. Bethesda: National Institutes of Health, 2016. - PubMed
    1. García‐Gutiérrez MS, Navarrete F, Sala F et al. Biomarkers in psychiatry: concept, definition, types and relevance to the clinical reality. Front Psychiatry 2020;11:432. - PMC - PubMed
    1. McGorry P, Keshavan M, Goldstone S et al. Biomarkers and clinical staging in psychiatry. World Psychiatry 2014;13:211‐23. - PMC - PubMed
    1. Lutz W, Schwartz B. Trans‐theoretical clinical models and the implementation of precision mental health care. World Psychiatry 2021;20:380‐1. - PMC - PubMed
    1. Maj M, van Os J, De Hert M et al. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry 2021;20:4‐33. - PMC - PubMed

LinkOut - more resources